Actively Recruiting

Age: 12Years - 20Years
All Genders
NCT05419960

Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-12

44

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

U

URC-CIC Paris Descartes Necker Cochin

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim is to determine whether vestibular deficits are present in OI, then to establish whether a correlation exists between genetic type, severity of OI and audiovestibular phenotype. OI patients aged 12 to 20 years will undergo an audiometric, immittance, and vestibular assessment. When hearing loss is conductive or mixed or in cases where vestibular deficits are identified, a CT scan without injection will be performed. In case of sensorineural hearing loss or abnormal CT results, an MRI will be performed.

CONDITIONS

Official Title

Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta

Who Can Participate

Age: 12Years - 20Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients between the ages of 12-20 years at the time of inclusion
  • Diagnosis of Osteogenesis Imperfecta of any type
  • Currently followed by a physician at the CRMR OI
  • Information and non-opposition of major patients, holders of parental authority and minor patients to participate in the study
Not Eligible

You will not qualify if you...

  • Patients with hearing loss of alternate origin e.g. Cochlear nerve deficiency, atresia, etc.
  • Neurological or developmental deficits limiting participation
  • Cervico-occipital instability e.g. Chiari's malformation
  • Limitations in mobility of the spine e.g. scoliosis, spinal fractural fusion
  • Ophthalmologic pathologies e.g. strabism or severe refraction disorder
  • Patients under AME (State Medical Aid)
  • Protected adult patients, adults unable to express their consent, pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Necker-Enfants Malades

Paris, France, 75015

Actively Recruiting

Loading map...

Research Team

N

Natalie Loundon, MD, PhD

CONTACT

H

Hélène Morel

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here